ARCHIVES

Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 28 | July 11, 2003

Download PDF Visit The Full Archive

Related Articles

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

Henschke Responds To Questions from The New York Times

April 29, 2011

NCI Advisory Group, other Cancer Meetings

July 29, 1988

Medicare’s 21% Pay Cut In Effect Today; Congress Unlikely To Abandon SGR

June 18, 2010

Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s

June 1, 2001